October 7, 2025

10x Genomics, Inc. (TXG)

⚠️ No article content returned.

..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a 107.81% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, has captured investor attention with its potential upside of 107.81%. This compelling figure is driven..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating the Virtual Healthcare Landscape with a 6.48% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) is carving out a significant niche in the rapidly evolving virtual healthcare sector. As a leader in health information services, Teladoc..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating Challenges with Strategic Insights for Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a name that resonates within the healthcare sector, particularly in the medical devices industry. With a market capitalization of..

Novavax, Inc. (NVAX) Investor Outlook: Navigating a 37.67% Potential Upside in the Biotech Sector

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has been at the forefront of vaccine innovation, especially in the wake of the COVID-19..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring an 81.83% Potential Upside in the Biotech Sector

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is capturing investor interest in the biotechnology sector, primarily due to its ambitious development pipeline and the significant potential upside of..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

AdaptHealth Corp. (AHCO) Stock Analysis: A 46% Potential Upside Ignites Investor Interest

AdaptHealth Corp. (NASDAQ: AHCO), a notable player in the healthcare sector, is making waves in the medical devices industry with its robust array of home medical..

Structure Therapeutics Inc. (GPCR): Analyst Ratings Point to a 155% Upside, Propelling Investor Interest

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with remarkable potential upside, as underscored by its analyst ratings. This United States-based biotechnology company,..

Phreesia, Inc. (PHR) Stock Analysis: Growth Potential in Health Information Services with a 44.8% Upside

Phreesia, Inc. (NYSE: PHR), a prominent player in the healthcare sector, is gaining considerable attention from investors due to its robust growth potential and significant analyst..

Dynavax Technologies Corp (DVAX) Stock Analysis: Exploring a 124.85% Potential Upside for Investors

Dynavax Technologies Corporation (NASDAQ: DVAX) has been a company of interest for investors seeking opportunities in the healthcare sector, particularly within the niche of specialty and..

Opko Health, Inc. (OPK) Stock Analysis: A High-Stakes Bet with 129% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, is making waves in the diagnostics and pharmaceuticals industries. Headquartered in Miami, Florida, the..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges with a Diverse Product Portfolio

BGM Group Ltd. (BGM), a company nestled in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, is making waves with its..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring Growth Potential with 9.89% Upside

In the ever-evolving healthcare sector, NeoGenomics, Inc. (NEO) stands out as a prominent player within the diagnostics and research industry. With a robust presence in the..

89bio, Inc. (ETNB) Stock Analysis: Unveiling a 97% Potential Upside in the Biotech Sector

For investors keeping a keen eye on the biotech sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing opportunity. With a market capitalization of $2.21 billion, this..

Premier, Inc. (PINC) Stock Analysis: Examining the 3.02% Dividend Yield Amidst a Challenging Revenue Landscape

Investors eyeing opportunities in the healthcare sector may want to consider Premier, Inc. (NASDAQ: PINC), a firm that operates in the health information services industry. With..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 31.66% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a key player in the healthcare sector, is currently drawing investor attention with a compelling 31.66% potential upside, according to..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 22.90% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector specializing in drug manufacturing with a focus on specialty and generic products, presents a..

Evolent Health, Inc (EVH) Stock Analysis: Exploring an 87% Potential Upside in Healthcare Tech

Evolent Health, Inc (NASDAQ: EVH) stands out as a compelling opportunity for investors interested in the healthcare technology sector. Operating at the intersection of health information..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Biotech Play with 41% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) has captured the attention of investors in the biotechnology sector, thanks to its promising pipeline and a notable potential upside. Headquartered..

Search

Funds

October 7, 2025

Search

Funds

October 7, 2025

FTSE 100

Funds